Announcements Trials
Browse Landscape

Status

Completed 3Terminated 1

Sponsor Class

OTHER 14INDUSTRY 4

Study Type

Interventional 8Observational 4

Sponsor

Conditions

Breast Neoplasms 468Neoplasms 316Carcinoma, Non-Small-Cell Lung 269Prostatic Neoplasms 215Colorectal Neoplasms 208Lung Neoplasms 178Multiple Myeloma 123Melanoma 110Carcinoma, Renal Cell 107Ovarian Neoplasms 94Carcinoma, Hepatocellular 78Pancreatic Neoplasms 69Urinary Bladder Neoplasms 65Stomach Neoplasms 64Neoplasm Metastasis 64Leukemia, Lymphocytic, Chronic, B-Cell 62Colonic Neoplasms 60Leukemia, Myeloid, Acute 53Uterine Cervical Neoplasms 50Recurrence 49Liver Neoplasms 46Lymphoma, Follicular 45Lymphoma 45Leukemia, Myelogenous, Chronic, BCR-ABL Positive 39Esophageal Neoplasms 37Precursor Cell Lymphoblastic Leukemia-Lymphoma 36Lymphoma, Large B-Cell, Diffuse 35Hematologic Neoplasms 35Head and Neck Neoplasms 35Lymphoma, Non-Hodgkin 34

Interventions

xiapex 1Surgical Procedures, Operative 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
INDUSTRY × Observational × Dupuytren Contracture × Clear all
NCT05877066 2024-04-16

GRASP-DC

Endo Pharmaceuticals

Terminated
130 enrolled

Dupuytren Contracture

NCT01444729 2017-10-26

Post Approval Commitment Study

Endo Pharmaceuticals

Completed
305 enrolled

Dupuytren Contracture

NCT00954746 2015-06-16

Longterm Observational Study in Subjects Treated With AA4500 in AUX-CC-854, 856, 857, 858 & 859

Endo Pharmaceuticals

Completed
645 enrolled

Connective Tissue Diseases, Dupuytren Contracture, Muscular Diseases, Musculoskeletal Diseases

NCT01715467 2015-06-16

CORRECT

Endo Pharmaceuticals

Completed
162 enrolled

Contracture, Dupuytren Contracture

Data powered by HemOnc (CC BY 4.0) Colophon âš¡